1
|
Rubio K, Müller JM, Mehta A, Watermann I, Olchers T, Koch I, Wessels S, Schneider MA, Araujo-Ramos T, Singh I, Kugler C, Stoleriu MG, Kriegsmann M, Eichhorn M, Muley T, Merkel OM, Braun T, Ammerpohl O, Reck M, Tresch A, Barreto G. Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC score. Discov Oncol 2023; 14:181. [PMID: 37787775 PMCID: PMC10547665 DOI: 10.1007/s12672-023-00799-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2023] [Accepted: 09/22/2023] [Indexed: 10/04/2023] Open
Abstract
BACKGROUND Lung cancer (LC) causes more deaths worldwide than any other cancer type. Despite advances in therapeutic strategies, the fatality rate of LC cases remains high (95%) since the majority of patients are diagnosed at late stages when patient prognosis is poor. Analysis of the International Association for the Study of Lung Cancer (IASLC) database indicates that early diagnosis is significantly associated with favorable outcome. However, since symptoms of LC at early stages are unspecific and resemble those of benign pathologies, current diagnostic approaches are mostly initiated at advanced LC stages. METHODS We developed a LC diagnosis test based on the analysis of distinct RNA isoforms expressed from the GATA6 and NKX2-1 gene loci, which are detected in exhaled breath condensates (EBCs). Levels of these transcript isoforms in EBCs were combined to calculate a diagnostic score (the LC score). In the present study, we aimed to confirm the applicability of the LC score for the diagnosis of early stage LC under clinical settings. Thus, we evaluated EBCs from patients with early stage, resectable non-small cell lung cancer (NSCLC), who were prospectively enrolled in the EMoLung study at three sites in Germany. RESULTS LC score-based classification of EBCs confirmed its performance under clinical conditions, achieving a sensitivity of 95.7%, 91.3% and 84.6% for LC detection at stages I, II and III, respectively. CONCLUSIONS The LC score is an accurate and non-invasive option for early LC diagnosis and a valuable complement to LC screening procedures based on computed tomography.
Collapse
Affiliation(s)
- Karla Rubio
- Université de Lorraine, CNRS, Laboratoire IMoPA, UMR 7365, 54000, Nancy, France
- Lung Cancer Epigenetic, Max-Planck-Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany
- Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, 02129, USA
- International Laboratory EPIGEN, Consejo de Ciencia y Tecnología del Estado de Puebla (CONCYTEP), Instituto de Ciencias, EcoCampus, Benemérita Universidad Autónoma de Puebla, 72570, Puebla, Mexico
| | - Jason M Müller
- Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany
- Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University of Cologne, Cologne, Germany
| | - Aditi Mehta
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Pharmaceutical Technology and Biopharmaceutics, Department of Pharmacy, Ludwig-Maximilians-University (LMU) Munich, 81377, Munich, Germany
- Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany
| | - Iris Watermann
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- LungenClinic Grosshansdorf (GHD), Airway Research Center North (ARCN), German Center for Lung Research (DZL), 22927, Großhansdorf, Germany
| | - Till Olchers
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- LungenClinic Grosshansdorf (GHD), Airway Research Center North (ARCN), German Center for Lung Research (DZL), 22927, Großhansdorf, Germany
| | - Ina Koch
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany
- Asklepios Biobank für Lungenerkrankungen, Asklepios Klinik Gauting GmbH, 82131, Gauting, Germany
| | - Sabine Wessels
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, 69126, Heidelberg, Germany
- Translational Lung Research Center Heidelberg (TLRC), 69120, Heidelberg, Germany
| | - Marc A Schneider
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, 69126, Heidelberg, Germany
- Translational Lung Research Center Heidelberg (TLRC), 69120, Heidelberg, Germany
| | - Tania Araujo-Ramos
- German Cancer Research Center (DKFZ) Heidelberg, Division Chronic Inflammation and Cancer, Emmy Noether Research Group Epigenetic Machineries and Cancer, 69120, Heidelberg, Germany
| | - Indrabahadur Singh
- German Cancer Research Center (DKFZ) Heidelberg, Division Chronic Inflammation and Cancer, Emmy Noether Research Group Epigenetic Machineries and Cancer, 69120, Heidelberg, Germany
| | - Christian Kugler
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- LungenClinic Grosshansdorf (GHD), Airway Research Center North (ARCN), German Center for Lung Research (DZL), 22927, Großhansdorf, Germany
| | - Mircea Gabriel Stoleriu
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany
- Asklepios Biobank für Lungenerkrankungen, Asklepios Klinik Gauting GmbH, 82131, Gauting, Germany
| | - Mark Kriegsmann
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Translational Lung Research Center Heidelberg (TLRC), 69120, Heidelberg, Germany
- Institute of Pathology, University of Heidelberg, 69120, Heidelberg, Germany
| | - Martin Eichhorn
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Translational Lung Research Center Heidelberg (TLRC), 69120, Heidelberg, Germany
- Department of Thoracic Surgery, University of Heidelberg, 69120, Heidelberg, Germany
| | - Thomas Muley
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, 69126, Heidelberg, Germany
- Translational Lung Research Center Heidelberg (TLRC), 69120, Heidelberg, Germany
| | - Olivia M Merkel
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Pharmaceutical Technology and Biopharmaceutics, Department of Pharmacy, Ludwig-Maximilians-University (LMU) Munich, 81377, Munich, Germany
- Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany
| | - Thomas Braun
- Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany
- Department of Cardiac Development, Max-Planck-Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany
| | - Ole Ammerpohl
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- Institute of Human Genetics, University Medical Center Ulm, 89081, Ulm, Germany
| | - Martin Reck
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany
- LungenClinic Grosshansdorf (GHD), Airway Research Center North (ARCN), German Center for Lung Research (DZL), 22927, Großhansdorf, Germany
| | - Achim Tresch
- Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
- Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University of Cologne, Cologne, Germany.
- Center for Data and Simulation Science, University of Cologne, Cologne, Germany.
| | - Guillermo Barreto
- Université de Lorraine, CNRS, Laboratoire IMoPA, UMR 7365, 54000, Nancy, France.
- Lung Cancer Epigenetic, Max-Planck-Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.
- Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany.
- German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Gießen, Germany.
| |
Collapse
|
4
|
Gruber B, Groeger T, Harrison D, Zimmermann R. Vacuum ultraviolet absorption spectroscopy in combination with comprehensive two-dimensional gas chromatography for the monitoring of volatile organic compounds in breath gas: A feasibility study. J Chromatogr A 2016; 1464:141-6. [PMID: 27545394 DOI: 10.1016/j.chroma.2016.08.024] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2016] [Revised: 08/09/2016] [Accepted: 08/10/2016] [Indexed: 12/17/2022]
Abstract
Vacuum ultraviolet (VUV) absorption spectroscopy was recently introduced as a new detection system for one, as well as comprehensive two-dimensional gas chromatography (GC×GC) and successfully applied to the analysis of various analytes in several matrices. In this study, its suitability for the analysis of breath metabolites was investigated and the impact of a finite volume of the absorption cell and makeup gas pressure was evaluated for volatile analytes in terms of sensitivity and chromatographic resolution. A commercial available VUV absorption spectrometer was coupled to GC×GC and applied to the analysis of highly polar volatile organic compounds (VOCs). Breath gas samples were acquired by needle trap micro extraction (NTME) during a glucose challenge and analysed by the applied technique. Regarding qualitative and quantitative information, the VGA-100 is compatible with common GC×GC detection systems like FID and even TOFMS. Average peak widths of 300ms and LODs in the lower ng range were achieved using GC×GC-VUV. Especially small oxygenated breath metabolites show intense and characteristic absorption patterns in the VUV region. Challenge responsive VOCs could be identified and monitored during a glucose challenge. The new VUV detection technology might especially be of benefit for applications in clinical research.
Collapse
Affiliation(s)
- Beate Gruber
- Joint Mass Spectrometry Centre, Comprehensive Molecular Analytics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; Joint Mass Spectrometry Centre, Chair of Analytical Chemistry, University of Rostock, Dr. Lorenz Weg 1, 18059 Rostock, Germany
| | - Thomas Groeger
- Joint Mass Spectrometry Centre, Comprehensive Molecular Analytics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; Joint Mass Spectrometry Centre, Chair of Analytical Chemistry, University of Rostock, Dr. Lorenz Weg 1, 18059 Rostock, Germany.
| | - Dale Harrison
- VUV Analytics, Inc., Austin, TX 78717, United States
| | - Ralf Zimmermann
- Joint Mass Spectrometry Centre, Comprehensive Molecular Analytics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; Joint Mass Spectrometry Centre, Chair of Analytical Chemistry, University of Rostock, Dr. Lorenz Weg 1, 18059 Rostock, Germany
| |
Collapse
|